Characterization of cytokine release syndrome (CRS) and neurological events (NEs) in the phase I TRANSCEND NHL 001 trial of lisocabtagene maraleucel (liso-cel) for patients (pts) with relapsed/refractory (R/R) large B-cell lymphoma (LBCL) Meeting Abstract
| Authors: | Abramson, J. S.; Siddiqi, T.; Gordon, L. I.; Lunning, M. A.; Wang, M.; Arnason, J. E.; Mehta, A. N.; Purev, E.; Maloney, D. G.; Andreadis, C.; Sehgal, A. R.; Solomon, S. R.; Ghosh, N.; Albertson, T. M.; Garcia, J.; Kostic, A.; Li, D.; Kim, Y.; Palomba, M. L. |
| Abstract Title: | Characterization of cytokine release syndrome (CRS) and neurological events (NEs) in the phase I TRANSCEND NHL 001 trial of lisocabtagene maraleucel (liso-cel) for patients (pts) with relapsed/refractory (R/R) large B-cell lymphoma (LBCL) |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368307403 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.e20046 |
| Notes: | Meeting Abstract: e20046 -- Source: Wos |
